SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Inhibrx Biosciences, Inc. (INBX) Reports Q3 2026 Results

Inhibrx Biosciences reported third-quarter 2026 financial results. The provided release contains no financial figures or comparisons.Material DetailsContext by AI AnalystThis is a routine quarterly disclosure from a clinical-stage biopharmaceutical company with two programs in ongoing clinical tria…

INBX
SquawkNews Desk

Related stories

Microsoft Restores Services After Hourslong Global Outage Microsoft said services were fully restored after an hourslong global outage. M impact | EQUITY | Nov 14, 2026, 09:12 AM UTC Rs.4K cr Ramayana movie VFX maker parent Prime Focus shares in focus after 14x profit jump in Q2; stock up 61% in a year New Delhi, Nov. 14 -- Prime Focus Ltd, the parent company of visual effects and animation studio DNEG, is likely to remain in focus on Monday after announcing its September-quarter L impact | EQUITY | Nov 14, 2026, 09:04 AM UTC Microsoft Restores Service After Global Outage Microsoft said its disruption to central cloud services is over. M impact | EQUITY | Nov 14, 2026, 09:01 AM UTC US Flights to Resume After Air Traffic Network Failure US flights are set to resume after an air traffic network failure disrupted operations. M impact | EQUITY | Nov 14, 2026, 08:06 AM UTC UniCredit Raises $3.5 Billion M impact | EQUITY | Nov 14, 2026, 08:03 AM UTC AMAT Shares Fall 2.58% as Headline Cites Record Q4 Revenue The headline also says 2027 demand is seen above 30%, but provides no further context. M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC